|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ricketts CJ, De Cubas AA, Fan H, Smith CC,
Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, et al:
The cancer genome atlas comprehensive molecular characterization of
renal cell carcinoma. Cell Rep. 23:313–326.e5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cancer Genome Atlas and Research Network:
Comprehensive molecular characterization of clear cell renal cell
carcinoma. Nature. 499:43–49. 2013. View Article : Google Scholar
|
|
4
|
Vasan N, Baselga J and Hyman DM: A view on
drug resistance in cancer. Nature. 575:299–309. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peters JM: The anaphase promoting
complex/cyclosome: A machine designed to destroy. Nat Rev Mol Cell
Biol. 7:644–656. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rankin S, Ayad NG and Kirschner MW:
Sororin, a substrate of the anaphase-promoting complex, is required
for sister chromatid cohesion in vertebrates. Mol Cell. 18:185–200.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haarhuis JHI, Elbatsh AMO and Rowland BD:
Cohesin and its regulation: On the logic of X-shaped chromosomes.
Dev Cell. 31:7–18. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ladurner R, Kreidl E, Ivanov MP, Ekker H,
Idarraga-Amado MH, Busslinger GA, Wutz G, Cisneros DA and Peters
JM: Sororin actively maintains sister chromatid cohesion. EMBO J.
35:635–653. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sjögren C and Nasmyth K: Sister chromatid
cohesion is required for postreplicative double-strand break repair
in Saccharomyces cerevisiae. Curr Biol. 11:991–995. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Watrin E and Peters JM: The cohesin
complex is required for the DNA damage-induced G2/M checkpoint in
mammalian cells. EMBO J. 28:2625–2635. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gruber S, Haering CH and Nasmyth K:
Chromosomal cohesin forms a ring. Cell. 112:765–777. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang N and Pati D: Sororin is a master
regulator of sister chromatid cohesion and separation. Cell Cycle.
11:2073–2083. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tian Y, Wu J, Chagas C, Du Y, Lyu H, He Y,
Qi S, Peng Y and Hu J: CDCA5 overexpression is an Indicator of poor
prognosis in patients with hepatocellular carcinoma (HCC). BMC
Cancer. 18:11872018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen A, Liu L, Chen H, Qi F, Huang Y, Lin
J, Sferra TJ, Sankararaman S, Wei L, Chu J, et al: Cell division
cycle associated 5 promotes colorectal cancer progression by
activating the ERK signaling pathway. Oncogenesis. 8:192019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang IW, Lin VCH, He HL, Hsu CT, Li CC,
Wu WJ, Huang CN, Wu TF and Li CF: CDCA5 overexpression is an
indicator of poor prognosis in patients with urothelial carcinomas
of the upper urinary tract and urinary bladder. Am J Transl Res.
7:710–722. 2015.PubMed/NCBI
|
|
16
|
Fu G, Xu Z, Chen X, Pan H, Wang Y and Jin
B: CDCA5 functions as a tumor promoter in bladder cancer by
dysregulating mitochondria-mediated apoptosis, cell cycle
regulation and PI3k/AKT/mTOR pathway activation. J Cancer.
11:2408–2420. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paner GP, Stadler WM, Hansel DE, Montironi
R, Lin DW and Amin MB: Updates in the eighth edition of the
tumor-node-metastasis staging classification for urologic cancers.
Eur Urol. 73:560–569. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Saremi N and Lam AK: Application of tissue
microarray in esophageal adenocarcinoma. Methods Mol Biol.
1756:105–118. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Faustino-Rocha A, Oliveira PA,
Pinho-Oliveira J, Teixeira-Guedes C, Soares-Maia R, da Costa RG,
Colaço B, Pires MJ, Colaço J, Ferreira R and Ginja M: Estimation of
rat mammary tumor volume using caliper and ultrasonography
measurements. Lab Anim (NY). 42:217–224. 2013. View Article : Google Scholar
|
|
21
|
Ma N, Kawanishi M, Hiraku Y, Murata M,
Huang GW, Huang Y, Luo DZ, Mo WG, Fukui Y and Kawanishi S: Reactive
nitrogen species-dependent DNA damage in EBV-associated
nasopharyngeal carcinoma: The relation to STAT3 activation and EGFR
expression. Int J Cancer. 122:2517–2525. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hanahan D: Hallmarks of cancer: New
dimensions. Cancer Discov. 12:31–46. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ui A, Chiba N and Yasui A: Relationship
among DNA double-strand break (DSB), DSB repair, and transcription
prevents genome instability and cancer. Cancer Sci. 111:1443–1451.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Waldman T: Emerging themes in cohesin
cancer biology. Nat Rev Cancer. 20:504–515. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu J, Zhu C, Yu Y, Wu W, Cao J, Li Z, Dai
J, Wang C, Tang Y, Zhu Q, et al: Systematic cancer-testis gene
expression analysis identified CDCA5 as a potential therapeutic
target in esophageal squamous cell carcinoma. EBioMedicine.
46:54–65. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen H, Chen J, Zhao L, Song W, Xuan Z,
Chen J, Li Z, Song G, Hong L, Song P and Zheng S: CDCA5,
Transcribed by E2F1, promotes oncogenesis by enhancing cell
proliferation and inhibiting apoptosis via the AKT pathway in
hepatocellular carcinoma. J Cancer. 10:1846–1854. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nguyen MH, Koinuma J, Ueda K, Ito T,
Tsuchiya E, Nakamura Y and Daigo Y: Phosphorylation and activation
of cell division cycle associated 5 by mitogen-activated protein
kinase play a crucial role in human lung carcinogenesis. Cancer
Res. 70:5337–5347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nowak SJ and Corces VG: Phosphorylation of
histone H3: A balancing act between chromosome condensation and
transcriptional activation. Trends Genet. 20:214–220. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lord CJ and Ashworth A: PARP inhibitors:
Synthetic lethality in the clinic. Science. 355:1152–1158. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mittal P and Roberts CWM: The SWI/SNF
complex in cancer-biology, biomarkers and therapy. Nat Rev Clin
Oncol. 17:435–448. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nishiyama T, Ladurner R, Schmitz J, Kreidl
E, Schleiffer A, Bhaskara V, Bando M, Shirahige K, Hyman AA,
Mechtler K and Peters JM: Sororin mediates sister chromatid
cohesion by antagonizing Wapl. Cell. 143:737–749. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Losada A: Cohesin in cancer: Chromosome
segregation and beyond. Nat Rev Cancer. 14:389–393. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bednarski JJ and Sleckman BP: At the
intersection of DNA damage and immune responses. Nat Rev Immunol.
19:231–242. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen Q, Sun L and Chen ZJ: Regulation and
function of the cGAS-STING pathway of cytosolic DNA sensing. Nat
Immunol. 17:1142–1149. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cai X, Chiu YH and Chen ZJ: The
cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling.
Mol Cell. 54:289–296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ishikawa H, Ma Z and Barber GN: STING
regulates intracellular DNA-mediated, type I interferon-dependent
innate immunity. Nature. 461:788–792. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schoggins JW, Wilson SJ, Panis M, Murphy
MY, Jones CT, Bieniasz P and Rice CM: A diverse range of gene
products are effectors of the type I interferon antiviral response.
Nature. 472:481–485. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang J, Lv X, Guo X, Dong Y, Peng P, Huang
F, Wang P, Zhang H, Zhou J, Wang Y, et al: Feedback activation of
STAT3 limits the response to PI3K/AKT/mTOR inhibitors in
PTEN-deficient cancer cells. Oncogenesis. 10:82021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Reisländer T, Groelly FJ and Tarsounas M:
DNA damage and cancer immunotherapy: A STING in the Tale. Mol Cell.
80:21–28. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Danial NN and Korsmeyer SJ: Cell death:
Critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schreiber V, Dantzer F, Ame JC and de
Murcia G: Poly(ADP-ribose): Novel functions for an old molecule.
Nat Rev Mol Cell Biol. 7:517–528. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Malanga M and Althaus FR: The role of
poly(ADP-ribose) in the DNA damage signaling network. Biochem Cell
Biol. 83:354–364. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Schumacher TN and Schreiber RD:
Neoantigens in cancer immunotherapy. Science. 348:69–74. 2015.
View Article : Google Scholar : PubMed/NCBI
|
